DexCom, Inc. - Common Stock (NQ:DXCM)

86.90 +1.54 (+1.80%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

50 51 Next >

DexCom Stock Earns Healthy Relative Strength Rating Upgrade ↗

December 05, 2023

In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday.

Via Investor's Business Daily

Analyst Expectations for DexCom's Future ↗

December 04, 2023

Via Benzinga

1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague ↗

December 04, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer, as well as an industry leader that could...

Via The Motley Fool

Investing $5,000 in These 3 Stocks Could Make You Rich ↗

November 27, 2023

Artificial intelligence should be a huge tailwind for all three of these stocks.

Via The Motley Fool

Topics Artificial Intelligence

Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗

November 22, 2023

Is DEXCOM INC (NASDAQ:DXCM) suited for growth investing?

Via Chartmill

Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

November 20, 2023

Via Benzinga

Looking Into DexCom's Recent Short Interest ↗

November 17, 2023

Via Benzinga

Is DexCom the Next Big Growth Stock? ↗

November 17, 2023

It has significant growth drivers in play, but competitors are making inroads too.

Via The Motley Fool

Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry ↗

November 16, 2023

Via Benzinga

Dexcom Announces Upcoming Conference Presentation

November 21, 2023

From DexCom, Inc.

Via Business Wire

3 Growth Stocks to Buy With $1,000 Right Now ↗

November 21, 2023

If you're having trouble finding your portfolio's next growth holding, here are three great options to choose from -- or you can choose all three.

Via The Motley Fool

Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. ↗

November 20, 2023

New medicines for weight loss and diabetes stand to disrupt the competitive scene.

Via The Motley Fool

3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist ↗

November 20, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying.

Via The Motley Fool

Behind the Scenes of DexCom's Latest Options Trends ↗

November 14, 2023

Via Benzinga

This Is What Whales Are Betting On DexCom ↗

November 09, 2023

Via Benzinga

In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. ↗

November 09, 2023

NASDAQ:DXCM is not too expensive for the growth it is showing.

Via Chartmill

Check Out What Whales Are Doing With DXCM ↗

November 06, 2023

Via Benzinga

2 Stock Split Growth Stocks to Buy and Hold ↗

November 19, 2023

These companies could continue delivering excellent results long after their most recent stock splits are forgotten.

Via The Motley Fool

Investing Lesson: Value Drivers ↗

November 18, 2023

Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value?

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 17, 2023

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

Could DexCom Stock Help You Become a Millionaire? ↗

November 16, 2023

DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future.

Via The Motley Fool

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

November 14, 2023

From DexCom, Inc.

Via Business Wire

Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore' ↗

November 13, 2023

Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

November 10, 2023

Via Benzinga

3 Earnings Winners Poised to Outperform the Market ↗

November 09, 2023

Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio?

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity ↗

November 08, 2023

Investors could be making a mistake by selling off these stocks this year.

Via The Motley Fool

3 Healthcare Stocks Getting Help From the Aging Population ↗

November 06, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Via InvestorPlace

1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid ↗

November 03, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a phenomenally cheap industry leader, as well as an exceptionally pricey company...

Via The Motley Fool

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.